Patent directory · USPTO A61K / A61P
Patents matching “inhibitor”
2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9839639
Neprilysin inhibitors
granted -
US 9834568
Kinase inhibitors and their uses
granted -
US 9833457
Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors
granted -
US 9833437
Small molecule inhibitor of MYD88 for therapeutic treatment against alphavirus and staphylococcal enterotoxin infections and toxin exposure
granted -
US 9828352
Phenyl carbamates and their use as inhibitors of the fatty acid amide hydrolase (FAAH) enzyme and modulators of the D3 dopamine receptor (D3DR)
granted -
US 9828367
Neprilysin inhibitors
granted -
US 9828373
2-amino-pyrido[2,3-D]pyrimidin-7(8H)-one derivatives as CDK inhibitors and uses thereof
granted -
US 9822068
Inhibitors of fatty acid amide hydrolase (FAAH) enzyme with improved oral bioavailability and their use as medicaments
granted -
US 9821054
Method of vaccination comprising a histone deacetylase inhibitor
granted -
US 9815796
Pyrimidone carboxamide compounds as PDE2 inhibitors
granted -
US 9809588
GLS1 inhibitors for treating disease
granted -
US 9809604
DGAT1 inhibitor and preparation method and use thereof
granted -
US 9809541
LSD1 inhibitors
granted -
US 9808459
Inhibitors of influenza viruses replication
granted -
US 9808458
Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
granted -
US 9803202
Oligonucleotide-based inhibitors comprising locked nucleic acid motif
granted -
US 9801863
Inhibitors of short-chain dehydrogenase activity for modulating hematopoietic stem cells and hematopoiesis
granted -
US 9802904
Inhibitors of the USP1/UAF1 deubiquitinase complex and uses thereof
granted -
US 9802949
Fused ring compounds as hepatitis C virus inhibitors, pharmaceutical compositions and uses thereof
granted -
US 9796671
Aurora kinase inhibitors
granted -
US 9796664
Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors
granted -
US 9790272
Stem cell factor inhibitor
granted -
US 9789095
Inhibitors of calcium-activated chloride channels
granted -
US 9790180
Piperidine derivatives as HDAC1/2 inhibitors
granted